PMH43 - COST-UTILITY ANALYSIS OF CARIPRAZINE COMPARED TO...

Value in Health 2018 / 10 Vol. 21

PMH43 - COST-UTILITY ANALYSIS OF CARIPRAZINE COMPARED TO RISPERIDONE AMONG PATIENTS WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN SELECTED CENTRAL AND EASTERN EUROPEAN COUNTRIES

Nemeth, B., Bendes, R., Nagy, B., Deak, I.A., Toth, B., Koczian, K., Horvath, M., Croitoru, C., Tarhajova, M., Psota, M., Kuchar, J., Bucek Psenkova, M., Vokó, Z.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.09.1678
Date:
October, 2018
File:
PDF, 725 KB
2018
Conversion to is in progress
Conversion to is failed